{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:01:50Z","timestamp":1777039310108,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board (SERB)","doi-asserted-by":"publisher","award":["SERB\/ECR\/2017\/000317"],"award-info":[{"award-number":["SERB\/ECR\/2017\/000317"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research (CSIR)","doi-asserted-by":"publisher","award":["37(1644)\/15\/EMR-II"],"award-info":[{"award-number":["37(1644)\/15\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2019,1,11]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Natriuretic peptide system (NPS) alterations are involved in pathogenesis of diabetic cardiomyopathy (DCM) and nephropathy (DN), however its epigenetic regulation is still unclear. Interestingly, histone acetylation epigenetically regulates neprilysin expression in Alzheimer\u2019s disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives:<\/jats:title><jats:p>The present study was aimed at delineating role of histone acetylation in regulation of NPS in DCM and DN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Streptozotocin (55 mg\/kg, i.p.)-induced diabetic male Wistar rats were used to mimic pathogenesis of DCM and DN. After haemodynamic measurements, all the rat\u2019s plasma, heart and kidney were collected for biochemistry, ELISA, protein isolation and western blotting, RT-PCR and chromatin immunoprecipitation (ChIP) assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Diabetic rats heart and kidney exhibited activation of NF-\u03baB and TGF-\u03b2 signalling with increased histone acetyl transferases (PCAF\/CBP) expressions and augmented H2AK5Ac, H2BK5Ac, H3K18Ac, and H4K8Ac levels. ChIP assay results showed increased enrichment of H3K18Ac and H2BK5Ac at Nppa, Nppb (Heart) and Mme promoter (Heart\/Kidney) in diabetic rats. Enrichment of H2AK5Ac was augmented on Nppa and Mme promoters in diabetic heart, while it remained unchanged on Nppb promoter in heart and Mme promoter in kidney.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Augmented histone acetylation at promoter regions of NPS gene(s), at least in a part, is responsible for increased expressions of ANP, BNP and NEP in diabetic heart and kidney. Hence, histone acetylation inhibitors can be considered as novel therapeutic targets against DCM and DN.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1874467212666181122092300","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T11:33:11Z","timestamp":1543491191000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Histone Acetylation Regulates Natriuretic Peptides and Neprilysin Gene Expressions in Diabetic Cardiomyopathy and Nephropathy"],"prefix":"10.1016","volume":"12","author":[{"given":"Vajir","family":"Malek","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan-333031, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan-333031, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Bhanudas","family":"Gaikwad","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan-333031, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","volume":"2","author":"Li G.","year":"2014","unstructured":"Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study:A 23-year follow-up study.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/cvr\/cvx018","volume":"113","author":"Chong C-R.","year":"2017","unstructured":"Chong C-R, Clarke K, Levelt E. Metabolic remodelling in diabetic cardiomyopathy.","journal-title":"Cardiovasc Res"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"Frati G.","year":"2017","unstructured":"Frati G, Schirone L, Chimenti I, Yee D, Biondi-Zoccai G, Volpe M, Sciarretta S. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.","journal-title":"Cardiovasc Res"},{"key":"ref=4","author":"Papadopoulou Marketou N.","year":"2017","unstructured":"Papadopoulou Marketou N, Chrousos GP, Kanaka Gantenbein C. Diabetic nephropathy in type 1 diabetes: A review of early natural history, pathogenesis, and diagnosis.","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.biopha.2017.04.024","volume":"90","author":"Malek V.","year":"2017","unstructured":"Malek V, Gaikwad AB. Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?","journal-title":"Biomed Pharmacother"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/14728222.2016.1254198","volume":"20","author":"Moro C.","year":"2016","unstructured":"Moro C. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.","journal-title":"Expert Opin Ther Targets"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","volume":"339","author":"Levin E.R.","year":"1998","unstructured":"Levin ER, Gardner DG, Samson WK. Natriuretic peptides.","journal-title":"N Engl J Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","volume":"318","author":"Felker G.M.","year":"2017","unstructured":"Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Mark DB, Pi\u00f1a IL, Passmore G. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: A randomized clinical trial.","journal-title":"JAMA"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cge.12121","volume":"84","author":"Keating S.","year":"2013","unstructured":"Keating S, El Osta A. Epigenetic changes in diabetes.","journal-title":"Clin Genet"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/cvr\/cvx070","volume":"113","author":"Perrino C.","year":"2017","unstructured":"Perrino C, Barab\u00e1si A-L, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW. Epigenomic and transcriptomic approaches in the post-genomic era: Path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.","journal-title":"Cardiovasc Res"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00125-017-4490-1","volume":"61","author":"Keating S.T.","year":"2018","unstructured":"Keating ST, van Diepen JA, Riksen NP, El-Osta A. Epigenetics in diabetic nephropathy, immunity and metabolism.","journal-title":"Diabetologia"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ki.2015.148","volume":"88","author":"Reddy M.A.","year":"2015","unstructured":"Reddy MA, Natarajan R. Recent developments in epigenetics of acute and chronic kidney diseases.","journal-title":"Kidney Int"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ki.2013.387","volume":"85","author":"Reddy M.A.","year":"2014","unstructured":"Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D, Alpers CE, Bomsztyk K, Natarajan R. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db\/db mice.","journal-title":"Kidney Int"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jff.2017.05.051","volume":"35","author":"Kadakol A.","year":"2017","unstructured":"Kadakol A, Malek V, Goru SK, Pandey A, Sharma N, Gaikwad AB. Esculetin ameliorates insulin resistance and type 2 diabetic nephropathy through reversal of histone H3 acetylation and H2A lysine 119 monoubiquitination.","journal-title":"J Funct Foods"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxlet.2017.08.011","volume":"280","author":"Pharaon L.F.","year":"2017","unstructured":"Pharaon LF, El-Orabi NF, Kunhi M, Al Yacoub N, Awad SM, Poizat C. Rosiglitazone Promotes Cardiac Hypertrophy and Alters Chromatin Remodeling in Isolated Cardiomyocytes.","journal-title":"Toxicol Lett"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCRESAHA.116.306819","volume":"118","author":"Keating S.T.","year":"2016","unstructured":"Keating ST, Plutzky J, El-Osta A. Epigenetic Changes in Diabetes and Cardiovascular Risk.","journal-title":"Circ Res"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11010-017-2993-1","volume":"432","author":"Berthiaume J.M.","year":"2017","unstructured":"Berthiaume JM, Hsiung C-h, Austin AB, McBrayer SP, Depuydt MM, Chandler MP, Miyagi M, Rosca MG. Methylene blue decreases mitochondrial lysine acetylation in the diabetic heart.","journal-title":"Mol Cell Biochem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4161\/15592294.2014.990780","volume":"10","author":"Huang J.","year":"2015","unstructured":"Huang J, Wan D, Li J, Chen H, Huang K, Zheng L. Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury.","journal-title":"Epigenetics"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12795","volume":"131","author":"Wang H.","year":"2014","unstructured":"Wang H, Sun M, Yang H, Tian X, Tong Y, Zhou T, Zhang T, Fu Y, Guo X, Fan D. Hypoxia-inducible factor-1\u03b1 mediates up-regulation of neprilysin by histone deacetylase-1 under hypoxia condition in neuroblastoma cells.","journal-title":"J Neurochem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.2013.266411","volume":"592","author":"Chen H.","year":"2014","unstructured":"Chen H, Li J, Jiao L, Petersen RB, Li J, Peng A, Zheng L, Huang K. Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse.","journal-title":"J Physiol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbadis.2014.11.006","volume":"1852","author":"Wang Y.","year":"2015","unstructured":"Wang Y, Wang Y, Luo M, Wu H, Kong L, Xin Y, Cui W, Zhao Y, Wang J, Liang G. Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300\/CBP-mediated histone acetylation.","journal-title":"Basis Dis"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jnc.12680","volume":"130","author":"Kerridge C.","year":"2014","unstructured":"Kerridge C, Belyaev ND, Nalivaeva NN, Turner AJ. The A\u03b2-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain.","journal-title":"J Neurochem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"Kilkenny C.","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.","journal-title":"PLoS Biol"},{"key":"ref=24","author":"Malek V.","year":"2018","unstructured":"Malek V, Bhanudas Gaikwad A. Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.","journal-title":"Cardiovasc Res"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1042\/BCJ20160595","volume":"473","author":"Goru S.K.","year":"2016","unstructured":"Goru SK, Kadakol A, Pandey A, Malek V, Sharma N, Gaikwad AB. Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7\/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis.","journal-title":"Biochem J"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/bph.13946","volume":"174","author":"Goru S.K.","year":"2017","unstructured":"Goru SK, Kadakol A, Malek V, Pandey A, Sharma N, Gaikwad AB. Diminazene aceturate prevents nephropathy by increasing glomerular Ace2 and At2 receptor expression in a rat model of type1 diabetes.","journal-title":"Br J Pharmacol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","volume":"172","author":"Curtis M.J.","year":"2015","unstructured":"Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander S, Giembycz MA, Gilchrist A, Hoyer D, Insel PA, Izzo AA. Experimental design and analysis and their reporting: new guidance for publication in BJP.","journal-title":"Br J Pharmacol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1262-3636(07)70059-9","volume":"29","author":"Cosson S.","year":"2003","unstructured":"Cosson S, Kevorkian J. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?","journal-title":"Diabetes Metab"},{"key":"ref=29","author":"Ryu Y.","year":"2016","unstructured":"Ryu Y, Jin L, Kee HJ, Piao ZH, Cho JY, Kim GR, Choi SY, Lin MQ, Jeong MH. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity.","journal-title":"Sci Rep"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"Shah M.S.","year":"2016","unstructured":"Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes.","journal-title":"Circ Res"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpendmet0894","volume":"4","author":"Dronavalli S.","year":"2008","unstructured":"Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy.","journal-title":"Nat Rev Endocrinol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"Tessarz P.","year":"2014","unstructured":"Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.201601116R","volume":"31","author":"Deb D.K.","year":"2017","unstructured":"Deb DK, Bao R, Li YC. Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.","journal-title":"FASEB J"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2337\/db13-1251","volume":"63","author":"Miao F.","year":"2014","unstructured":"Miao F, Chen Z, Genuth S, Paterson A, Zhang L, Wu X, Li SM, Cleary P, Riggs A, Harlan DM. Evaluating the Role of Epigenetic histone modifications in the Metabolic Memory of Type 1 Diabetes.","journal-title":"Diabetes"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"25869","DOI":"10.1074\/jbc.M112.375204","volume":"287","author":"Kadiyala C.S.R.","year":"2012","unstructured":"Kadiyala CSR, Zheng L, Du Y, Yohannes E, Kao H-Y, Miyagi M, Kern TS. Acetylation of retinal histones in diabetes increases inflammatory proteins effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC).","journal-title":"J Biol Chem"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M311786200","volume":"279","author":"Miao F.","year":"2004","unstructured":"Miao F, Gonzalo IG, Lanting L, Natarajan R. chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.","journal-title":"J Bio Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1096\/fj.201700891R","volume":"32","author":"Li Y.","year":"2018","unstructured":"Li Y, Li X, He K, Li B, Liu K, Qi J, Wang H, Wang Y, Luo W. C-peptide prevents NF-\u03baB from recruiting p300 and binding to the inos promoter in diabetic nephropathy.","journal-title":"FASEB J"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"ra43","DOI":"10.1126\/scisignal.2003389","volume":"6","author":"Kato M.","year":"2013","unstructured":"Kato M, Dang V, Wang M, Park JT, Deshpande S, Kadam S, Mardiros A, Zhan Y, Oettgen P, Putta S. TGF-\u03b2 induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy.","journal-title":"Sci Signal"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"F601","DOI":"10.1152\/ajprenal.00523.2012","volume":"304","author":"Yuan H.","year":"2013","unstructured":"Yuan H, Reddy MA, Sun G, Lanting L, Wang M, Kato M, Natarajan R. Involvement of p300\/CBP and epigenetic histone acetylation in TGF-\u03b21-mediated gene transcription in mesangial cells.","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=40","volume":"97","author":"Chen B.","year":"2011","unstructured":"Chen B, Xiong Z, Ma Y, Liu C, Dong Y. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a\/MAFbx signalling pathway.","journal-title":"Heart"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/jmf.2017.3968","volume":"20","author":"Kim A.","year":"2017","unstructured":"Kim A, Yun J-M. Combination treatments with luteolin and fisetin enhance anti-inflammatory effects in high glucose-treated THP-1 cells through histone acetyltransferase\/histone deacetylase regulation.","journal-title":"J Med Food"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"22623","DOI":"10.18632\/oncotarget.8033","volume":"7","author":"Shi M.","year":"2016","unstructured":"Shi M, Lu X-J, Zhang J, Diao H, Li G, Xu L, Wang T, Wei J, Meng W, Ma J-L. Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53-and caspase-3-mediated mechanisms.","journal-title":"Oncotarget"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1681\/ASN.2006070754","volume":"17","author":"Kato M.","year":"2006","unstructured":"Kato M, Yuan H, Xu Z-G, Lanting L, Li S-L, Wang M, Hu MC-T, Reddy MA, Natarajan R. Role of the Akt\/FoxO3a pathway in TGF-\u03b21-mediated mesangial cell dysfunction: A novel mechanism related to diabetic kidney disease.","journal-title":"J Am Soc Nephrol"},{"key":"ref=44","first-page":"6","author":"Wang Z.","year":"2011","unstructured":"Wang Z, Yang D, Zhang X, Li T, Li J, Tang Y, Le W. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons.","journal-title":"PLoS One"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/167658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:56:44Z","timestamp":1746572204000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/167658\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467212666181122092300","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}